Your Catalyst To a Lucrative Business
Table of Content of Pharmacovigilance Market
Chapter 1 . Executive Summary 1.1 . Pharmacovigilance - Industry Summary and Critical Success Factors ( CSFs )
Chapter 2 . Pharmacovigilance Industry Outlook 2.1 . Market Segmentation 2.2 . Market Size and Growth Prospects 2.3 . Pharmacovigilance - Market dynamics 2.3.1 . Market Driver Analysis 2.3.2 . Market Restraint Analysis 2.4 . Key Opportunities Prioritized 2.5 . Pharmacovigilance - PESTEL Analysis 2.6 . Pharmacovigilance Company Market Share Analysis , 2013
Chapter 3 . Pharmacovigilance Clinical Trial Phase Outlook 3.1 . Pharmacovigilance market share , by clinical trial phase , 2013 & 2020 3.2 . Preclinical
3.2.1 . Preclinical Market Estimates and Forecasts , 2012 - 2020 ( USD Million ) 3.3 . Phase 0
3.3.1 . Phase 0 Market Estimates and Forecasts , 2012 - 2020 ( USD Million ) 3.4 . Phase I
3.4.1 . Phase I Market Estimates and Forecasts , 2012 - 2020 ( USD Million ) 3.5 . Phase II
3.5.1 . Phase II Market Estimates and Forecasts , 2012 - 2020 ( USD Million ) 3.6 . Phase III
3.6.1 . Phase III Market Estimates and Forecasts , 2012 - 2020 ( USD Million ) 3.7 . Phase IV
3.7.1 . Phase IV Market Estimates and Forecasts , 2012 - 2020 ( USD Million )
Chapter 4 . Pharmacovigilance Type of Service Provider Outlook 4.1 . Pharmacovigilance market share , by type of service provider , 2013 & 2020 4.2 . In- House
4.2.1 . In-House Market Estimates and Forecasts , 2012 - 2020 ( USD Million ) 4.3 . Contract Outsourcing
4.3.1 . Contract Outsourcing Market Estimates and Forecasts , 2012 - 2020 ( USD Million )
Follow Us :